Demonstration of antibodies against human malignant melanoma by immunofluorescence.
- Journal
- PubMed
In The Last Decade
doi.org/w67675868 →Countries where authors are citing Demonstration of antibodies against human malignant melanoma by immunofluorescence.
This map shows the geographic impact of Demonstration of antibodies against human malignant melanoma by immunofluorescence.. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Demonstration of antibodies against human malignant melanoma by immunofluorescence. with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Demonstration of antibodies against human malignant melanoma by immunofluorescence. more than expected).
Fields of papers citing Demonstration of antibodies against human malignant melanoma by immunofluorescence.
This network shows the impact of Demonstration of antibodies against human malignant melanoma by immunofluorescence.. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the Demonstration of antibodies against human malignant melanoma by immunofluorescence..
About Demonstration of antibodies against human malignant melanoma by immunofluorescence.
This paper, published in 1968, received 321 indexed citations . Written by Morton Dl, Malmgren Ra, Holmes Ec and Ketcham As covering the research area of Radiology, Nuclear Medicine and Imaging. It is primarily cited by scholars working on Immunology (233 citations), Oncology (151 citations), Radiology, Nuclear Medicine and Imaging (88 citations), Molecular Biology (80 citations) and Epidemiology (36 citations). Published in PubMed.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.
This paper is also available at doi.org/w67675868.